Pabla, Navjotsingh <br/><br/>
ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis.  [electronic resource] 

 -  The Journal of biological chemistry  Mar 2008 
 - 6572-83 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>0021-9258 
<br/><br/><label>Standard No.: </label>10.1074/jbc.M707568200  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--adverse effects<br/>Apoptosis--drug effects<br/>Ataxia Telangiectasia Mutated Proteins<br/>Cell Cycle Proteins--genetics<br/>Cell Line, Transformed<br/>Checkpoint Kinase 1<br/>Checkpoint Kinase 2<br/>Cisplatin--adverse effects<br/>DNA Damage--drug effects<br/>DNA-Binding Proteins--genetics<br/>Gene Deletion<br/>Histones--genetics<br/>Humans<br/>Kidney Diseases--chemically induced<br/>Kidney Tubules, Proximal--injuries<br/>Neoplasms--complications<br/>Proteasome Endopeptidase Complex--genetics<br/>Protein Kinases--genetics<br/>Protein Serine-Threonine Kinases--genetics<br/>Rats<br/>Signal Transduction--drug effects<br/>Tumor Suppressor Protein p53--genetics<br/>Tumor Suppressor Proteins--genetics